Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
Q4 2021 vs. Q3 2021
How the institutions holding Alexion Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 7 | 2 | −5 |
| Shares | 5.80K | 86 | −5.71K (−98.5%) |
| Value | $823.0K | $14.0K | −$809.0K (−98.3%) |
New holders (1)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sierra Capital LLC | 26 | $0 | 0.00% |
Sold out (6)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Brinker Capital Investments, LLC | 2,302 | $423.0K |
| Neo Ivy Capital Management | 2,587 | $290.0K |
| TD Ameritrade Investment Management, LLC | 741 | $85.0K |
| CVA Family Office, LLC | 100 | $11.0K |
| Meeder Asset Management Inc | 3 | $1.00K |
| Barclays PLC | 6 | – |